跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAR-DAPSONE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MAR-DAPSONE
Authorized
STANDARD
MAR-DAPSONE
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bc8003c1abf9b632
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
bc8003c1abf9b632
Drug Approval Canada Name
MAR-DAPSONE
Product Name
MAR-DAPSONE
Status
Marketed
Status Date
2018-11-13
Original Market Date
2018-11-13
Din
02481227
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:16.92
Atc Original
J04BA02 DAPSONE
Atc Name
j 04 ba 02
Aig Number
0106115001
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
DAPSONE
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bc8003c1abf9b632
Type
Standard
Back to Health Canada Approvals